Impact de l’épidémie de COVID-19 sur les demandes de prise en charge initiale pour cancer du sein

Héquet, Delphine; Rodrigues, Manuel; Tardivon, A.; Langer, A.; Dahan, Méryl; Rouzier, Roman; Takanen, Silvia; Kirova, Yulia; Bidard, François‐Clément; Cottu, Paul

doi:10.1016/j.bulcan.2020.04.004

Cited by 11 publications

(8 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Additionally, fewer requests for domestic violence shelter were made (Council of Europe, 2020 ). Similar to these decreases in domestic violence reports, some studies reported a substantial decrease in medical consultations (Héquet et al, 2020 ; Mehrote, Chernew, Linetsky, Hatch, & Cutler, 2020 ; Roy, 2020 ). According to one survey in France, the main reasons for this decrease were the fear of being infected and the fear of disturbing medical doctors during the COVID-19 pandemic (Roy, 2020 ).…”

Section: Why Has the Covid-19 Pandemic Led To An Increase In Domesticmentioning

confidence: 64%

COVID-19: urgency for distancing from domestic violence

Ertan

El‐Hage

Thierrée

et al. 2020

European Journal of Psychotraumatology

View full text Add to dashboard Cite

Background Although COVID-19 is a major worldwide health threat, there is another global public health emergency that is becoming a growing challenge. Domestic violence is a public health and human rights issue that primarily affects women and children worldwide. Several countries have reported a significant increase in domestic violence cases since the COVID-19-induced lockdowns and physical distancing measures were implemented. The COVID-19 health crisis is exacerbating another pre-existing public health problem by increasing the severity and frequency of domestic violence, thus demonstrating the need to adopt significant and long-term measures. Objective Therefore, it is urgently necessary to promote and increase actions and policies to guarantee the safety and dignity of all victims of domestic violence worldwide. Methods This paper describes preventive measures and action plans to combat violence against women and children during the COVID-19 pandemic. Conclusion The prevention of domestic violence must indeed be every government’s priority and every citizen’s responsibility.

show abstract

Section: Why Has the Covid-19 Pandemic Led To An Increase In Domesticmentioning

confidence: 64%

COVID-19: urgency for distancing from domestic violence

Ertan

El‐Hage

Thierrée

et al. 2020

European Journal of Psychotraumatology

View full text Add to dashboard Cite

show abstract

“…Among analytical cross-sectional studies, the quality was considered moderate for 13 41 , 46 , 49 , 52 , 53 , 58 , 61 , 68 , 71 , 78 , 89 , 97 , 99 and low for the remaining 14. 51 , 54 , 55 , 63 , 64 , 69 , 73 , 74 , 82 , 88 , 91 , 92 , 96 , 98 …”

Section: Resultsmentioning

confidence: 99%

Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review

Riera

Bagattini

Pacheco

et al. 2021

JCO Global Oncology

339

304

View full text Add to dashboard Cite

PURPOSE There has been noteworthy concern about the impact of COVID-19 pandemic on health services including the management of cancer. In addition to being considered at higher risk for worse outcomes from COVID-19, people with cancer may also experience disruptions or delays in health services. This systematic review aimed to identify the delays and disruptions to cancer services globally. METHODS This is a systematic review with a comprehensive search including specific and general databases. We considered any observational longitudinal and cross-sectional study design. The selection, data extraction, and methodological assessment were performed by two independent reviewers. The methodological quality of the studies was assessed by specific tools. The delays and disruptions identified were categorized, and their frequency was presented. RESULTS Among the 62 studies identified, none exhibited high methodological quality. The most frequent determinants for disruptions were provider- or system-related, mainly because of the reduction in service availability. The studies identified 38 different categories of delays and disruptions with impact on treatment, diagnosis, or general health service. Delays or disruptions most investigated included reduction in routine activity of cancer services and number of cancer surgeries; delay in radiotherapy; and delay, reschedule, or cancellation of outpatient visits. Interruptions and disruptions largely affected facilities (up to 77.5%), supply chain (up to 79%), and personnel availability (up to 60%). CONCLUSION The remarkable frequency of delays and disruptions in health care mostly related to the reduction of the COVID-19 burden unintentionally posed a major risk on cancer care worldwide. Strategies can be proposed not only to mitigate the main delays and disruptions but also to standardize their measurement and reporting. As a high number of publications continuously are being published, it is critical to harmonize the upcoming reports and constantly update this review.

show abstract

“…We found that being proactive for patients with suspected COVID-19 significantly reduced the risk of death, as opposed to stopping cancer therapy after the diagnosis of COVID-19, which appeared to be too late. However, the reduction in COVID-19 mortality during cancer treatment is only part of the task, as cancer mortality could increase in the months and years to come because of delays in diagnosis or treatment during the pandemic [7,8]. Moreover, it will be interesting to assess whether the changes in treatment during the first wave, although clearly beneficial at the time, will have negative effects in the long term with an evolution of the oncological disease [9].…”

Section: Discussionmentioning

confidence: 99%

COVID-19 in Patients with Cancer: A Retrospective Study of 212 Cases from a FrenchSARS-CoV-2 Cluster During the First Wave of theCOVID-19 Pandemic

et al. 2021

View full text Add to dashboard Cite

We describe a large series of patients with solid tumors in an early COVID‐19 cluster in the eastern part of France. From February to May 2020, this multicenter retrospective study enrolled 212 patients with cancer under treatment or on follow‐up for any type of malignant solid tumor and positive for SARS‐CoV‐2. The mortality rate was 30%. Patients with gastrointestinal cancers were identified as a subset of more vulnerable patients; immunotherapy and radiotherapy within 3 months from COVID‐19 diagnosis were risk factors for death. The reported data support the essential need to be proactive and weigh the risks of morbidity from COVID‐19 against the magnitude of benefits of intended cancer therapies during this pandemic. Implications for Practice This article supports the essential need to be proactive (treatment delay or modification) in oncology in the setting of pandemic. This study identified patients with gastrointestinal cancers as a more vulnerable subset of patients with cancer and found that immunotherapy and radiotherapy within 3 months from COVID‐19 diagnosis to be risk factors for death. The reported data indicate the necessity of weighing the risks of morbidity from COVID‐19 against the magnitude of benefits of intended cancer therapies in any future wave of COVID‐19.

show abstract

Impact de l’épidémie de COVID-19 sur les demandes de prise en charge initiale pour cancer du sein

Cited by 11 publications

References 1 publication

COVID-19: urgency for distancing from domestic violence

COVID-19: urgency for distancing from domestic violence

Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review

COVID-19 in Patients with Cancer: A Retrospective Study of 212 Cases from a FrenchSARS-CoV-2 Cluster During the First Wave of theCOVID-19 Pandemic

Contact Info

Product

Resources

About